Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reducing the Incidence and Severity of Arm Lymphedema With Axillary Reverse Mapping and Implementation of a Lymphedema Screening and Intervention Program

NCT01276054 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT01276054
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01276054 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reducing the Incidence and Severity of Arm Lymphedema With Axillary Reverse Mapping and Implementation of a Lymphedema Screening and Intervention Program
Lead sponsor
University of Southern California
Phase
Phase 2
Overall status
Terminated
Start date
December 31, 2010
Completion date
October 31, 2011
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphedema, recurrent breast cancer, stage ia breast cancer, stage ib breast cancer, stage ii breast cancer